Xue Zhou

823 total citations
30 papers, 269 citations indexed

About

Xue Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Xue Zhou has authored 30 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Xue Zhou's work include Ferroptosis and cancer prognosis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Epigenetics and DNA Methylation (3 papers). Xue Zhou is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Epigenetics and DNA Methylation (3 papers). Xue Zhou collaborates with scholars based in China, United States and Australia. Xue Zhou's co-authors include Ning Wang, Yuefeng Zhang, Xiaowei Zhu, Zhonghui Gao, Wence Xu, Hui Jiang, Xiao‐Li Xie, Zhenduo Cui, Yanqin Liang and Zhaoyang Li and has published in prestigious journals such as Advanced Materials, Diabetes and Oncogene.

In The Last Decade

Xue Zhou

28 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Zhou China 11 124 47 45 40 34 30 269
Qinfeng Zhou China 11 191 1.5× 167 3.6× 23 0.5× 3 0.1× 40 1.2× 21 316
Eiji Shinoda Japan 7 87 0.7× 25 0.5× 16 0.4× 4 0.1× 13 0.4× 11 238
Weiliang Sun China 7 101 0.8× 28 0.6× 41 0.9× 1 0.0× 61 1.8× 12 287
Yudan Xie China 8 188 1.5× 102 2.2× 22 0.5× 18 0.5× 12 298
Nolan Bick United States 7 100 0.8× 42 0.9× 36 0.8× 12 0.4× 8 258
Xiaoye Yuan China 8 71 0.6× 44 0.9× 20 0.4× 5 0.1× 55 1.6× 19 331
Dongjie Ma China 13 202 1.6× 157 3.3× 117 2.6× 8 0.2× 43 434
Changjiang Luo China 9 171 1.4× 57 1.2× 35 0.8× 12 0.4× 27 278
Zizhuo Li China 11 135 1.1× 44 0.9× 16 0.4× 43 1.3× 24 268
Liyuan Liu China 9 88 0.7× 29 0.6× 15 0.3× 49 1.4× 21 244

Countries citing papers authored by Xue Zhou

Since Specialization
Citations

This map shows the geographic impact of Xue Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Zhou more than expected).

Fields of papers citing papers by Xue Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Zhou. The network helps show where Xue Zhou may publish in the future.

Co-authorship network of co-authors of Xue Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Zhou. A scholar is included among the top collaborators of Xue Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Zhou. Xue Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Xue, Wence Xu, Jiewen Xiao, et al.. (2025). Tuning Active Hydrogen via Spillover Enables the Wide‐Potential Electrochemical Reduction of Nitrate to Ammonia. Advanced Materials. 38(9). e18272–e18272.
3.
Liu, Minghao, Kaiyu Wang, Yan Zhang, et al.. (2025). Mechanistic Study of Protein Interaction with Natto Inhibitory Peptides Targeting Xanthine Oxidase: Insights from Machine Learning and Molecular Dynamics Simulations. Journal of Chemical Information and Modeling. 65(7). 3682–3696. 2 indexed citations
4.
Liu, Ying, Chuxiao Xiong, Xiaohuan Wang, et al.. (2025). Epidemiology characteristics of the drinking patterns and alcohol consumption among adults in Hainan Province, China. Frontiers in Public Health. 13. 1490439–1490439. 1 indexed citations
5.
Zhou, Xue, et al.. (2025). Precision medicine for acute kidney injury: Baicalein-nanodrug delivery system combat oxidative stress and repair mitochondrial dysfunction. International Journal of Pharmaceutics. 678. 125694–125694. 2 indexed citations
6.
7.
Zhou, Xue, Wence Xu, Yanqin Liang, et al.. (2024). Dynamically Restructuring Nanoporous Cu–Co Electrocatalyst for Efficient Nitrate Electroreduction to Ammonia. ACS Catalysis. 14(16). 12251–12259. 41 indexed citations
8.
Zhou, Xue, et al.. (2023). PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer. Clinical Epigenetics. 15(1). 123–123. 9 indexed citations
9.
Zhou, Xue, et al.. (2022). Expression of CCL2, FOS, and JUN May Help to Distinguish Patients With IgA Nephropathy From Healthy Controls. Frontiers in Physiology. 13. 840890–840890. 8 indexed citations
10.
Kang, Ning, Xiao‐Li Xie, Xue Zhou, et al.. (2022). Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer. BMC Gastroenterology. 22(1). 190–190. 23 indexed citations
11.
Wang, Ning, et al.. (2022). Comprehensive analysis identifies ARHGEF6 as a potential prognostic and immunological biomarker in lung adenocarcinoma. Computers in Biology and Medicine. 153. 106448–106448. 7 indexed citations
12.
Zhou, Xue, et al.. (2021). KAT2B is an immune infiltration-associated biomarker predicting prognosis and response to immunotherapy in non‐small cell lung cancer. Investigational New Drugs. 40(1). 43–57. 14 indexed citations
13.
Yang, Yuying, et al.. (2021). Efficacy and safety of Shumian capsules in treating insomnia. Medicine. 100(50). e28194–e28194. 7 indexed citations
14.
Zhou, Xue, et al.. (2021). Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4 in pancreatic cancer. Investigational New Drugs. 39(6). 1469–1483. 11 indexed citations
15.
Zhou, Xue, Yuefeng Zhang, & Ning Wang. (2021). Regulation and Potential Biological Role of Fibroblast Growth Factor 21 in Chronic Kidney Disease. Frontiers in Physiology. 12. 764503–764503. 7 indexed citations
16.
Jiang, Xiaoyu, Jie Yin, Xiao‐Li Xie, et al.. (2021). RNF141 interacts with KRAS to promote colorectal cancer progression. Oncogene. 40(39). 5829–5842. 5 indexed citations
17.
Wang, Ning, Xue Zhou, Fei Tang, Xue Wang, & Xiaowei Zhu. (2021). Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(6). 1153–1165. 14 indexed citations
18.
Nie, Wenbo, et al.. (2021). Review of prophylactic swallowing interventions for head and neck cancer. International Journal of Nursing Studies. 123. 104074–104074. 18 indexed citations
19.
20.
Xie, Yun, Shaoxin Wang, Weiwei Sha, et al.. (2008). Effects and mechanism of glucagon-like peptide-1 on injury of rats cardiomyocytes induced by hypoxia-reoxygenation. Chinese Medical Journal. 121(21). 2134–2138. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qinfeng Zhou Breakdown of academic impact, for papers by Eiji Shinoda Breakdown of academic impact, for papers by Weiliang Sun Breakdown of academic impact, for papers by Yudan Xie Breakdown of academic impact, for papers by Nolan Bick Breakdown of academic impact, for papers by Xiaoye Yuan Breakdown of academic impact, for papers by Dongjie Ma Breakdown of academic impact, for papers by Changjiang Luo Breakdown of academic impact, for papers by Zizhuo Li Breakdown of academic impact, for papers by Liyuan Liu
Rankless by CCL
2026